Table 2.
HRs of bleeding for HD versus PD
| Time-dependent | ||||||
|---|---|---|---|---|---|---|
| Incidence rate/1000 | Crude | Adjusteda | Adjustedb | adjustedb | ||
| Dialysis modality | n | person-years | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) |
| PD | 534 | 34.6 | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
| HD | 1211 | 60.8 | 1.7 (1.2–2.5) | 1.5 (1.0–2.1) | 1.4 (1.0–2.1) | 1.5 (1.0–2.2) |
a
Adjusted for age, sex, primary kidney disease, prior bleeding, cardiovascular disease, antiplatelet drug use, vitamin K antagonist use and erythropoietin use.
b
Adjusted for age, sex, primary kidney disease, prior bleeding, cardiovascular disease, antiplatelet drug use, vitamin K antagonist use, erythropoietin use, arterial hypertension, residual GFR, haemoglobin and albumin.